Armis Advisers’s Zoetis ZTS Stock Holding History

Armis Advisers’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,466	Closed	-$212K	–	459
2025 Q3	$212K	Buy	+1,466	New	+$222K	0.02%	301

Other funds holding ZTS

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armis Advisers's ZTS Position: Q4 2025 in Review

Armis Advisers sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 1,466 shares — an estimated $212K sold.

Armis Advisers first reported a position in ZTS in Q3 2025 and held it in 1 quarter. The position peaked at $212K in Q3 2025. 1,679 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

Armis Advisers reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
Armis Advisers sold 1,466 Zoetis shares in Q4 2025, an estimated $212K.
Armis Advisers first reported a position in Zoetis in Q3 2025 and held it in 1 quarter.
Armis Advisers's Zoetis position peaked at $212K in Q3 2025.
1,679 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Armis Advisers's 13F filing for Q4 2025, filed 24 Mar 2026.